Exercise-intolerance and exercise-induced rhabdomyolisis: Etiology and diagnosis;Intolérance à l'effort et rhabdomyolyses d'effort: Étiologies et démarche diagnostique

Revue Neurologique

Volumn 160, Issue 2, 2004, Pages 217-223

  Laforet P ^a   Eymard, B ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE MONOPHOSPHATE DEAMINASE; CARNITINE PALMITOYLTRANSFERASE; CREATINE KINASE; MUSCLE ENZYME; MUSCLE PROTEIN; PHOSPHORYLASE KINASE;

BICYCLE ERGOMETRY; BLOOD SAMPLING; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CONFERENCE PAPER; DIAGNOSTIC ACCURACY; DIFFERENTIAL DIAGNOSIS; ENZYME ANALYSIS; ENZYME BLOOD LEVEL; ENZYME DEFICIENCY; EXERCISE; EXERCISE TEST; EXERCISE TOLERANCE; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; MUSCLE BIOPSY; MUSCLE METABOLISM; MUSCULAR DYSTROPHY; PHOSPHORUS NUCLEAR MAGNETIC RESONANCE; RHABDOMYOLYSIS; WESTERN BLOTTING;

EID: 1542374154     PISSN: 00353787     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0035-3787(04)70894-2     Document Type: Conference Paper

References (18)

1. CHAUSSAIN M, CAMUS F, DEFOLIGNY C, EYMARD B, FARDEAU M. (1992). Respiratory and metabolic data of a maximal exercise test in patients with exercise intolerance in McArdle's disease and mitochondrial myopathies. Eur J Med, 1: 457-463.
2. DI MAURO S. (1999). Exercise intolerance and the mitochondrial respiratory chain. J Neurol Sci, 20: 387-393.
3. DUBOC D, JEHENSON P, TRAN DINH S, MARSAC C, SYROTA A, FARDEAU M. (1987). Phosphorus NMR spectroscopy study of muscular enzyme deficiencies involving glycogenosis and glycolysis. Neurology, 37: 663-671.
4. GOSPE SM JR, LAZARO RP, LAVA NS. (1989). Familial X-linked myalgia and cramps: A non-progressive myopathy associated with a deletion in the dystrophin gene. Neurology, 39: 1277-1280.
5. HALLER RG, WYRICK P, CAVENDER D, WALL A, VISSING J. (1998). Aerobic conditioning: an effective therapy in McArdle's disease. Neurology, 50: A 369.
6. HOGREL JY, LAFORET P, BEN AYOU R, CHEVROT M, EYMARD B, LOMBES A. (2001). A non-ischemic forearm exercise test for the screening of patients with exercise intolerance. Neurology, 56: 1733-1738.
7. JENSEN TD, KAZEMI-ESFARJANI P, SKOMOROWSKA E, VISSING J. (2002). A forearm exercise screening test for mitochondrial myopathy. Neurology, 58: 1533-1538.
8. KAZEMI-ESFARJANI P, SKOMOROWSKA E, JENSEN TD, HALLER RG, VISSING J. (2002). A nonischemic forearm exercise test for McArdle disease. Ann Neurol, 52: 153-159.
9. LAFORET P, EYMARD B, LOMBES A, et al. (1996). Intolérance à l'effort par déficit en phosphorylase-kinase musculaire. Apport des investigations métaboliques in vivo. Rev Neurol, 152: 458-464.
10. LAFORET P, WARY C, DUTEIL S, et al. (2003). Exploration de l'intolérance à l'exercice par spectroscopie RMN du phosphore des muscles fléchisseurs plantaires. Rev Neurol, 159: 56-67.
11. LINDNER A, REICHERT N, EICHHORN M, ZIERZ S. (2001). Acute compartment syndrome after forearm ischemic work test in a patient with McArdle's disease. Neurology, 56: 1779-1780.
12. MERCELIS R, MARTOIN J-J, DE BARSY T, VAN DEN BERGHE G. (1987). Myoadenylate deaminase deficiency: absence of correlation with exercise intolerance in 452 muscle biopsies. J Neurol, 234: 385.
13. MIYAJIMA H, ORII KE, SHINDO Y, et al. (1997). Mitochondrial trifunctional protein deficiency associated with recurrent myoglobinuria in adolescence. Neurology, 49: 833-837.
14. SAUDUBRAY JM, MARTIN D, DE LONLAY P, et al. (1999). Recognition and management of fatty acid oxidation defects: a series of 107 patients. J Inher Metab Dis, 22: 488-502.
15. TAIVASSALO T, DE STEFANO N, ARGOV Z, et al. (1998). Effects of aerobic training in patients with mitochondrial myopathies. Neurology, 50: 1055-1060.
16. TONIN P, LEWIS P, SERVIDEI S, DI MAURO S. (1990). Metabolic causes of myoglobinuria. Ann Neurol, 27: 181-185.
17. TSUJINO S, SHANSKE S, DI MAURO S. (1993). Molecular genetic heterogeneity of myophosphorylase deficiency (Mc Ardle's disease). N Eng J Med, 329: 241-245.
18. VERZIJL HTFM, VAN ENGELEN BGM, LUYTEN JAFM et al. (1998). Genetic characteristics of myoadenylate deaminase deficiency. Ann Neurol, 44: 140-143.